Alok Dalal
Stock Analyst at Jefferies
(3.51)
# 2,262
Out of 5,014 analysts
92
Total ratings
59.7%
Success rate
6.8%
Average return
Main Sectors:
Stocks Rated by Alok Dalal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Reiterated: Buy | ₹6,500 → ₹6,400 | ₹5,199 | +23.11% | 6 | Aug 20, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Reiterated: Buy | ₹9,700 → ₹10,350 | ₹8,102 | +27.75% | 5 | Aug 17, 2026 | |
| NSE: EMCURE Emcure Pharmaceuticals Limited | Reiterated: Buy | ₹2,100 → ₹2,320 | ₹1,956 | +18.62% | 9 | Aug 11, 2026 | |
| NSE: ENTERO Entero Healthcare Solutions Limited | Reiterated: Buy | ₹1,500 → ₹1,800 | ₹1,666 | +8.04% | 7 | Aug 11, 2026 | |
| NSE: GLAND Gland Pharma Limited | Upgraded: Buy | ₹2,080 → ₹3,350 | ₹2,908 | +15.19% | 5 | Aug 11, 2026 | |
| NSE: SAILIFE Sai Life Sciences Limited | Reiterated: Buy | ₹1,270 → ₹1,610 | ₹1,537 | +4.73% | 5 | Aug 11, 2026 | |
| NSE: COHANCE Cohance Lifesciences Limited | Reiterated: Sell | ₹300.00 → ₹350.00 | ₹443.55 | -21.09% | 2 | Aug 6, 2026 | |
| NSE: MEDANTA Global Health Limited | Reiterated: Buy | ₹1,500 → ₹1,660 | ₹1,363 | +21.83% | 6 | Aug 4, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Reiterated: Buy | ₹3,000 → ₹3,220 | ₹2,507 | +28.46% | 7 | Jul 31, 2026 | |
| NSE: CIPLA Cipla Limited | Reiterated: Sell | ₹1,170 | ₹1,340 | -12.69% | 8 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,100 → ₹1,700 | ₹1,995 | -14.77% | 4 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,380 → ₹1,500 | ₹937.10 | n/a | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,400 → ₹2,250 | ₹2,020 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,210 → ₹1,100 | ₹1,213 | n/a | 2 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,620 → ₹1,700 | ₹1,361 | n/a | 3 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,350 → ₹1,150 | ₹1,145 | n/a | 3 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹6,280 → ₹6,200 | ₹9,209 | n/a | 2 | May 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹260.00 | ₹199.82 | n/a | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,850 → ₹3,140 | ₹3,550 | n/a | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹890.00 → ₹650.00 | ₹360.40 | n/a | 2 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹860.00 → ₹850.00 | ₹776.45 | n/a | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,260 → ₹2,265 | ₹1,809 | n/a | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | ₹400.00 | ₹370.00 | n/a | 1 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $68 → $12 | $12.62 | n/a | 4 | Jan 30, 2024 |
Alkem Laboratories Limited
Aug 20, 2026
Reiterated: Buy
Price Target: ₹6,500 → ₹6,400
Current: ₹5,199
Upside: +23.11%
Apollo Hospitals Enterprise Limited
Aug 17, 2026
Reiterated: Buy
Price Target: ₹9,700 → ₹10,350
Current: ₹8,102
Upside: +27.75%
Emcure Pharmaceuticals Limited
Aug 11, 2026
Reiterated: Buy
Price Target: ₹2,100 → ₹2,320
Current: ₹1,956
Upside: +18.62%
Entero Healthcare Solutions Limited
Aug 11, 2026
Reiterated: Buy
Price Target: ₹1,500 → ₹1,800
Current: ₹1,666
Upside: +8.04%
Gland Pharma Limited
Aug 11, 2026
Upgraded: Buy
Price Target: ₹2,080 → ₹3,350
Current: ₹2,908
Upside: +15.19%
Sai Life Sciences Limited
Aug 11, 2026
Reiterated: Buy
Price Target: ₹1,270 → ₹1,610
Current: ₹1,537
Upside: +4.73%
Cohance Lifesciences Limited
Aug 6, 2026
Reiterated: Sell
Price Target: ₹300.00 → ₹350.00
Current: ₹443.55
Upside: -21.09%
Global Health Limited
Aug 4, 2026
Reiterated: Buy
Price Target: ₹1,500 → ₹1,660
Current: ₹1,363
Upside: +21.83%
Mankind Pharma Limited
Jul 31, 2026
Reiterated: Buy
Price Target: ₹3,000 → ₹3,220
Current: ₹2,507
Upside: +28.46%
Cipla Limited
Jul 28, 2026
Reiterated: Sell
Price Target: ₹1,170
Current: ₹1,340
Upside: -12.69%
Jul 28, 2026
Reiterated: Hold
Price Target: ₹1,100 → ₹1,700
Current: ₹1,995
Upside: -14.77%
Aug 14, 2025
Reiterated: Buy
Price Target: ₹1,380 → ₹1,500
Current: ₹937.10
Upside: n/a
Aug 7, 2025
Upgraded: Buy
Price Target: ₹2,400 → ₹2,250
Current: ₹2,020
Upside: n/a
Jul 24, 2025
Reiterated: Sell
Price Target: ₹1,210 → ₹1,100
Current: ₹1,213
Upside: n/a
May 31, 2025
Reiterated: Hold
Price Target: ₹1,620 → ₹1,700
Current: ₹1,361
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: ₹1,350 → ₹1,150
Current: ₹1,145
Upside: n/a
May 18, 2025
Reiterated: Hold
Price Target: ₹6,280 → ₹6,200
Current: ₹9,209
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: ₹260.00
Current: ₹199.82
Upside: n/a
Apr 30, 2025
Reiterated: Buy
Price Target: ₹2,850 → ₹3,140
Current: ₹3,550
Upside: n/a
Apr 25, 2025
Reiterated: Hold
Price Target: ₹890.00 → ₹650.00
Current: ₹360.40
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: ₹860.00 → ₹850.00
Current: ₹776.45
Upside: n/a
Jan 31, 2025
Reiterated: Buy
Price Target: ₹2,260 → ₹2,265
Current: ₹1,809
Upside: n/a
Jan 6, 2025
Upgraded: Hold
Price Target: ₹400.00
Current: ₹370.00
Upside: n/a
Jan 30, 2024
Downgraded: Sell
Price Target: $68 → $12
Current: $12.62
Upside: n/a